Evidence map›Paper›PMID 29636777›Full record

ArticleEvidence-based complementary and alternative medicine : eCAM2018

Antitumor Mechanisms of Curcumae Rhizoma Based on Network Pharmacology.

Yan-Hua Bi, Li-Hua Zhang, Shao-Jun Chen, Qing-Zhi Ling

Abstract read
In one paragraph

Article in Evidence-based complementary and alternative medicine : eCAM, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Role ofArchives of Razi Institute · 2024
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Anticancer Effect of Radix Astragali on Cholangiocarcinoma In Vitro and Its Mechanism via Network Pharmacology.Medical science monitor : international medical journal of experimental and clinical research · 2020
    Article
  11. Article
  12. Article
  13. Article
  14. Systematic Elucidation of the Mechanism ofEvidence-based complementary and alternative medicine : eCAM · 2020
    Article
  15. Article
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Yan-Hua BiThe Children's Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
Li-Hua ZhangDepartment of Traditional Chinese Medicine, Zhejiang Pharmaceutical College, Ningbo, China.
Shao-Jun ChenDepartment of Traditional Chinese Medicine, Zhejiang Pharmaceutical College, Ningbo, China.ORCID 0000-0002-5744-1910
Qing-Zhi LingSchool of Medical Technology, Ningbo College of Health Science, Ningbo, China.ORCID 0000-0002-4451-1537

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Curcumae Rhizoma, a traditional Chinese medication, is commonly used in both traditional treatment and modern clinical care. Its anticancer effects have attracted a great deal of attention, but the mechanisms of action remain obscure. In this study, we screened for the active compounds of Curcumae Rhizoma using a drug-likeness approach. Candidate protein targets with functions related to cancer were predicted by reverse docking and then checked by manual search of the PubMed database. Potential target genes were uploaded to the GeneMANIA server and DAVID 6.8 database for analysis. Finally, compound-target, target-pathway, and compound-target-pathway networks were constructed using Cytoscape 3.3. The results revealed that the anticancer activity of Curcumae Rhizoma potentially involves 13 active compounds, 33 potential targets, and 31 signaling pathways, thus constituting a "multiple compounds, multiple targets, and multiple pathways" network corresponding to the concept of systematic actions in TCM. These findings provide an overview of the anticancer action of Curcumae Rhizoma from a network perspective, as well as setting an example for future studies of other materials used in TCM.

Identifiers

PMID29636777
PMCPMC5832109

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.